Literature DB >> 1520761

Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review.

F Derouin1, A Devergie, P Auber, E Gluckman, B Beauvais, Y J Garin, M Lariviere.   

Abstract

We report seven cases of cerebral or disseminated toxoplasmosis that occurred following bone marrow transplantation (BMT) and review the other 24 cases described in the literature. For all the cases, toxoplasmosis occurred within 6 months of BMT, with the highest incidence in the second and third months. Twenty-four of 26 recipients tested serologically before BMT were positive for Toxoplasma gondii, a finding that supports the view that such cases result from reactivation of latent infection. At the onset of clinical symptoms, IgG antibody titers were unchanged or decreased in 23 of 25 documented cases, and IgM antibodies were detected in two cases. Antemortem diagnosis was made in 16 cases and was based on the response to specific therapy in six cases and/or the demonstration of the parasite in body fluids or tissues in 10 cases. Autopsy was performed in 19 cases and revealed that infection was not restricted to the brain but either involved lung or heart tissue or was disseminated in 14 cases.

Entities:  

Mesh:

Year:  1992        PMID: 1520761     DOI: 10.1093/clinids/15.2.267

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients.

Authors:  B Mechain; Y J Garin; F Robert-Gangneux; J Dupouy-Camet; F Derouin
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

2.  Comparison of PCR-enzyme-linked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient.

Authors:  Jean Menotti; Gustavo Vilela; Stéphane Romand; Yves Jean-François Garin; Lionel Ades; Eliane Gluckman; Francis Derouin; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 4.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis.

Authors:  K J Helton; G Maron; E Mamcarz; V Leventaki; Z Patay; Z Sadighi
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

6.  Value of detecting immunoglobulin E antibodies for the serological diagnosis of Toxoplasma gondii infection.

Authors:  U Gross; O Keksel; M L Dardé
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

7.  Dizziness and confusion after bone marrow transplantation.

Authors:  D O'Shaughnessy; J M Goldman; M Roddie; J B Schofield
Journal:  BMJ       Date:  1994-07-23

8.  Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii.

Authors:  C A Hunter; J S Abrams; M H Beaman; J S Remington
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 9.  Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review.

Authors:  S Scerra; H Coignard-Biehler; F Lanternier; F Suarez; C Charlier-Woerther; M-E Bougnoux; J Gilquin; M Lecuit; O Hermine; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-18       Impact factor: 3.267

10.  [Female patient with organic psychosyndrome and neurological focal signs after immunosuppressant therapy].

Authors:  P Kühnlein; M Ringhoffer; H Tumani; H J Gdynia
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.